Abbott Laboratories logo

Abbott Laboratories (ABT)

Market Open
16 Jun, 17:25
NYSE NYSE
$
89. 59
+0.92
+1.0432%
$
153.59B Market Cap
36.49 P/E Ratio
0.28% Div Yield
1.78M Volume
4.44 Eps
$ 88.67
Previous Close
Analysts:
Add Transaction
Day Range
88.83 90.23
Year Range
81.97 139.06
Want to track ABT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Abbott Labs and Reckitt Benckiser shares surge on court's baby formula ruling

Abbott Labs and Reckitt Benckiser shares surge on court's baby formula ruling

A court in St. Louis, Missouri ruled in favor of Abbott Laboratories and Reckitt Benckiser over claims their specialized baby formula caused users to develop a bowel disease called NEC

Marketwatch | 1 year ago
Abbott, Reckitt cleared of liability in latest preterm formula case

Abbott, Reckitt cleared of liability in latest preterm formula case

Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's debilitating intestinal disease, a jury found on Thursday in a lawsuit accusing them of failing to warn of their premature baby formulas' risks, a victory for the two companies following large losses in similar trials.

Reuters | 1 year ago
Levi & Korsinsky, LLP Announces Investigation Abbott Laboratories Employees Credit Union (“ALECU”)

Levi & Korsinsky, LLP Announces Investigation Abbott Laboratories Employees Credit Union (“ALECU”)

NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Abbott Laboratories Employees Credit Union ("ALECU") recently disclosed a data breach that compromised the sensitive personal data of thousands of customers.This data breach has led to concerns over the security of sensitive private information entrusted ALECU. WHAT'S THIS ABOUT?

Accesswire | 1 year ago
Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead

Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead

A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for premature babies caused a severe intestinal illness.

Reuters | 1 year ago
Abbott Laboratories Employees Credit Union ("ALECU") Data Breach - Levi & Korsinsky, LLP Launches Investigation

Abbott Laboratories Employees Credit Union ("ALECU") Data Breach - Levi & Korsinsky, LLP Launches Investigation

NEW YORK, NY / ACCESSWIRE / October 30, 2024 / Abbott Laboratories Employees Credit Union ("ALECU") recently disclosed a data breach that compromised the sensitive personal data of thousands of customers.This data breach has led to concerns over the security of sensitive private information entrusted to ALECU. WHAT'S THIS ABOUT?

Accesswire | 1 year ago
These Are The Top Health Stocks to Own for Buy-and-Hold Investing

These Are The Top Health Stocks to Own for Buy-and-Hold Investing

Investors looking for health-related buy-and-hold stocks must look no further than this list. The stocks on this list are market leaders in healthcare, producing sustainable growth with healthy balance sheets, impressive value, and broad market support.

Marketbeat | 1 year ago
Levi & Korsinsky, LLP Investigates Abbott Laboratories Employees Credit Union ("ALECU") Data Breach

Levi & Korsinsky, LLP Investigates Abbott Laboratories Employees Credit Union ("ALECU") Data Breach

NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Abbott Laboratories Employees Credit Union ("ALECU") recently disclosed a data breach that compromised the sensitive personal data of thousands of customers. This data breach has led to concerns over the security of sensitive private information entrusted to ALECU.

Accesswire | 1 year ago
Here's Why You Should Retain ABT Stock in Your Portfolio Now

Here's Why You Should Retain ABT Stock in Your Portfolio Now

Investors feel optimistic about Abbott's robust strength in the Diagnostics and Nutrition business. Yet, unfavorable forex impacts are concerning.

Zacks | 1 year ago
My Best Dividend Aristocrats For November 2024

My Best Dividend Aristocrats For November 2024

The ProShares S&P 500 Dividend Aristocrats ETF went on a great run during Q3, gaining 11.6% during the quarter. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 39 months of tracking these strategies, all 3 strategies are generating a CAGR superior to NOBL while also offering a higher dividend yield.

Seekingalpha | 1 year ago
ABT's New Trial on Advanced Heart Failure Outcomes Set to Boost Stock

ABT's New Trial on Advanced Heart Failure Outcomes Set to Boost Stock

Abbott initiates the TEAM-HF trial to improve outcomes for advanced heart failure.

Zacks | 1 year ago
Abbott Laboratories Employees Credit Union (“ALECU”) Data Breach under Investigation by Levi & Korsinsky

Abbott Laboratories Employees Credit Union (“ALECU”) Data Breach under Investigation by Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / October 28, 2024 / Abbott Laboratories Employees Credit Union ("ALECU") recently disclosed a data breach that compromised the sensitive personal data of thousands of customers. This data breach has led to concerns over the security of sensitive private information entrusted to ALECU.

Accesswire | 1 year ago
Growing Biosimilars Business Supports ABT Stock, Macro Issues Hurt

Growing Biosimilars Business Supports ABT Stock, Macro Issues Hurt

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.

Zacks | 1 year ago
Loading...
Load More